BTK inhibitors
The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I or pharmaceutically acceptable salts thereof. Formula I or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds in the treatment of Btk mediated disorders.
Merck Sharp & Dohme Corp.
A C A C A
A61P C07D A61K C07D A61P
inventional inventional inventional inventional inventional
Arto D. Joseph Ronald M. Jian Deodialsingh Younong
Krikorian Kozlowski Kim Liu Guiadeen Yu